Cite
HARVARD Citation
Rubinstein, J. et al. (2020). EBV‐directed viral‐specific T‐lymphocyte therapy for the treatment of EBV‐driven lymphoma in two patients with primary immunodeficiency and DNA repair defects. Pediatric blood & cancer. 67 (3), p. n/a. [Online].